Transdermal Selegiline: Mechanism of Action

Among the pharmacological options for MDD treatment, selegiline stands out, particularly in its transdermal form. Transdermal selegiline offers a novel approach to delivering this medication, promising efficacy with reduced side effects.

Transdermal administration offers an alternative route for drug delivery, bypassing the gastrointestinal system and delivering the medication directly into the bloodstream through the skin. In the case of selegiline, this method of delivery has been optimized to provide steady plasma concentrations while minimizing the risk of adverse effects.

But what exactly is its mechanism of action?

Watch our YouTube video summarizing this topic:

TRANSDERMAL SELEGILINE: MECHANISM OF ACTION?

DETAILED LECTURE FOR ACADEMY MEMBERS:

Transdermal Selegiline for MDD

FOR ACADEMY MEMBERS
ACADEMY

JOIN EMAIL NEWSLETTER (FREE):

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 150/YR
  •  
STUDENTS
$ 99/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2024 All Rights Reserved.

Related Articles